Globin Solutions, Inc.
PrivateLast Round
Grant
Mar 1, 2020
Total Funding Raised
$9.25M
Company Overview
Globin Solutions, Inc. is a biotechnology company that researches and develops protein-based antidotal therapies for carbon monoxide poisoning.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Globin Solutions, Inc. Comparables
Compare Globin Solutions, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prolong Pharmaceuticals, LLC | 70% | |
| HbO2 Therapeutics | 66% | |
| KaloCyte, Inc. | 64% |
Globin Solutions, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 1, 2020 | ||||
| Series A | Apr 30, 2018 |
Globin Solutions, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| University of Pittsburgh Investment Office | Series A |
| National Institute of Environmental Health Sciences | Grant |
| National Institute of Environmental Health Sciences | Grant |
| UPMC Enterprises | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2020
$1.75M grant from National Institute of Environmental Health Sciences and NIH RADx.
- Apr 30, 2018
Raised $8M with participation from UPMC Enterprises and University of Pittsburgh.
Globin Solutions, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Globin Solutions, Inc.'s valuation, stock price, and market status.
Is Globin Solutions, Inc. a public or private company?
Globin Solutions, Inc. is a private company.
What is the current stock price of Globin Solutions, Inc.?
Globin Solutions, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Globin Solutions, Inc. worth (valuation)?
Valuation information for Globin Solutions, Inc. is not publicly available.
Can I buy Globin Solutions, Inc. stock?
Globin Solutions, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Globin Solutions, Inc.'s last funding round?
Globin Solutions, Inc.'s most recent funding round was Grant on March 1, 2020.
Who are the main investors in Globin Solutions, Inc.?
Key investors in Globin Solutions, Inc. include NIH RADx, University of Pittsburgh, National Institute of Environmental Health Sciences, UPMC Enterprises.
Will Globin Solutions, Inc. IPO soon?
No public IPO plans have been announced for Globin Solutions, Inc..
How can I track Globin Solutions, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Globin Solutions, Inc.'s secondary market activity and sign up for updates.